THROMBOXAN-REZEPTOR-ANTAGONISTEN

Patent europeic · EP3310756 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3310756
Numer da la dumonda
EP16739541
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
13-06-2016
Publitgà
25-04-2018
Concedì
09-12-2020
La protecziun finescha il pli tard
12-06-2036
Proxima taxa annuala scadenta
30-06-2027
Classas IPC
C07C 311/58 (2006.01)
A61K 31/277 (2006.01)
A61P 7/02 (2006.01)
Prioritad
US 201562180317 P 16.06.2015
Dumonda PCT
PCT/IB2016/000960 13.06.2016
Publicaziun PCT
WO2016/203314 22.12.2016
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-07-2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. 01-07-2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  3. 04-07-2024

    Midada

    Published in Swissreg on 04.07.2024

  4. 01-07-2023

    Midada

    Published in Swissreg on 01.07.2023

  5. 06-07-2022

    Midada

    Published in Swissreg on 06.07.2022

  6. 27-10-2021

    Midada

    Published in Swissreg on 27.10.2021

  7. 04-03-2021

    Represchentant inscrit

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 04.03.2021

  8. 09-12-2020

    Concedì

    Published in Swissreg on 09.12.2020

Partidas

Inventur

KINSELLA, B., Therese

Blackrock Co. Dublin, IE

REID, Helen

Dublin 13, IE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.